1sm2

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
Interleukin-2 tyrosine kinase, Itk, is an important member of the Tec, family of non-receptor tyrosine kinases that play a central role in, signaling through antigen receptors such as the T-cell receptor, B-cell, receptor, and Fcepsilon. Selective inhibition of Itk may be an important, way of modulating many diseases involving heightened or inappropriate, activation of the immune system. In addition to an unliganded, nonphophorylated Itk catalytic kinase domain, we determined the crystal, structures of the phosphorylated and nonphosphorylated kinase domain bound, to staurosporine, a potent broad-spectrum kinase inhibitor. These, structures are useful for the design of novel, highly potent and selective, Itk inhibitors and provide insight into the influence of inhibitor binding, and phosphorylation on the conformation of Itk.
+
Interleukin-2 tyrosine kinase, Itk, is an important member of the Tec family of non-receptor tyrosine kinases that play a central role in signaling through antigen receptors such as the T-cell receptor, B-cell receptor, and Fcepsilon. Selective inhibition of Itk may be an important way of modulating many diseases involving heightened or inappropriate activation of the immune system. In addition to an unliganded nonphophorylated Itk catalytic kinase domain, we determined the crystal structures of the phosphorylated and nonphosphorylated kinase domain bound to staurosporine, a potent broad-spectrum kinase inhibitor. These structures are useful for the design of novel, highly potent and selective Itk inhibitors and provide insight into the influence of inhibitor binding and phosphorylation on the conformation of Itk.
==Disease==
==Disease==
Line 18: Line 18:
[[Category: Transferase]]
[[Category: Transferase]]
[[Category: Brown, K.]]
[[Category: Brown, K.]]
-
[[Category: Cheetham, G.M.T.]]
+
[[Category: Cheetham, G M.T.]]
[[Category: Dedi, N.]]
[[Category: Dedi, N.]]
-
[[Category: Dunster, N.J.]]
+
[[Category: Dunster, N J.]]
-
[[Category: Fleming, M.A.]]
+
[[Category: Fleming, M A.]]
-
[[Category: Frantz, J.D.]]
+
[[Category: Frantz, J D.]]
-
[[Category: Long, J.M.]]
+
[[Category: Long, J M.]]
-
[[Category: Renwick, S.B.]]
+
[[Category: Renwick, S B.]]
-
[[Category: Tanner, A.J.]]
+
[[Category: Tanner, A J.]]
-
[[Category: Vial, S.C.M.]]
+
[[Category: Vial, S C.M.]]
[[Category: STU]]
[[Category: STU]]
[[Category: immunology]]
[[Category: immunology]]
[[Category: protein kinase]]
[[Category: protein kinase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 16:54:15 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:02:54 2008''

Revision as of 13:02, 21 February 2008


1sm2, resolution 2.3Å

Drag the structure with the mouse to rotate

Crystal structure of the phosphorylated Interleukin-2 tyrosine kinase catalytic domain

Contents

Overview

Interleukin-2 tyrosine kinase, Itk, is an important member of the Tec family of non-receptor tyrosine kinases that play a central role in signaling through antigen receptors such as the T-cell receptor, B-cell receptor, and Fcepsilon. Selective inhibition of Itk may be an important way of modulating many diseases involving heightened or inappropriate activation of the immune system. In addition to an unliganded nonphophorylated Itk catalytic kinase domain, we determined the crystal structures of the phosphorylated and nonphosphorylated kinase domain bound to staurosporine, a potent broad-spectrum kinase inhibitor. These structures are useful for the design of novel, highly potent and selective Itk inhibitors and provide insight into the influence of inhibitor binding and phosphorylation on the conformation of Itk.

Disease

Known disease associated with this structure: Polyhydramnios, megalencephaly, and symptomatic epilepsy OMIM:[608626]

About this Structure

1SM2 is a Single protein structure of sequence from Homo sapiens with as ligand. Active as Transferase, with EC number and 2.7.10.2 2.7.10.1 and 2.7.10.2 Full crystallographic information is available from OCA.

Reference

Crystal structures of interleukin-2 tyrosine kinase and their implications for the design of selective inhibitors., Brown K, Long JM, Vial SC, Dedi N, Dunster NJ, Renwick SB, Tanner AJ, Frantz JD, Fleming MA, Cheetham GM, J Biol Chem. 2004 Apr 30;279(18):18727-32. Epub 2004 Feb 6. PMID:14766749

Page seeded by OCA on Thu Feb 21 15:02:54 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools